Embassy Develop (EMBDL)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity of 0.46 is moderate for a capital-intensive real estate developer, so the balance sheet is not stretched beyond control.
• Book value of ₹35.45 provides some tangible asset support, and a P/B of 1.34 is not an extreme speculative premium.
• Promoter holding of 42.65% provides partial alignment and incentive to protect shareholder value.
• The company still generates ₹212 Cr in quarterly sales, showing it has some operational scale.

Concerns

• Latest quarter net loss of ₹234 Cr exceeds quarterly sales of ₹212 Cr, indicating severe cash burn.
• Sales growth of -34.70% and profit growth of -979.85% show collapsing operations.
• ROE at -4.97% and ROCE at 3.19% reflect poor capital allocation and no excess returns on capital.
• Piotroski F-Score of 3/9 and FairStock Score of 0/100 signal weak financial health and high risk.

AI Analysis

At ₹47.58, Embassy Develop has a market cap of ₹8,401 Cr, but the P/E is meaningless because there are no earnings to justify it. The latest quarter tells the story: sales of only ₹212 Cr against a net loss of ₹234 Cr. That is cash destruction, not compounding. Book value is ₹35.45 per share, yet I am asked to pay 1.34 times that for a business whose return on equity is -4.97% and whose ROCE is just 3.19%. A profitable developer should not earn 3.19% on capital; this is far below what I would demand. Sales have fallen 34.70% and profits have gone -979.85%, so there is no positive momentum. The Piotroski score of 3/9 confirms weak financial health, and FairStock's 0/100 score is a red flag. Debt/equity of 0.46 is not alarming, but with operating losses and zero dividend, leverage becomes a risk rather than a tool. Promoter holding at 42.65% is respectable, but ownership alone does not create a moat. This is a residential and commercial real estate developer in a cyclical, capital-intensive industry. It is subject to demand, interest rates, and project execution; there is no durable competitive advantage visible from these numbers. The stock has fallen from ₹105.70 to ₹47.58, but a falling price is not value. Graham taught me to buy with a margin of safety. Here, I would be paying a premium to book for an asset base earning negative returns. No dividend. No earnings. No evidence of a turnaround. This is not a wonderful business at a fair price; it is a difficult cyclical undertaking that I would leave on the shelf until profitability and returns show real recovery.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer